Compare RGEN & VNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGEN | VNO |
|---|---|---|
| Founded | 1981 | 1946 |
| Country | United States | United States |
| Employees | N/A | 3145 |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 5.7B |
| IPO Year | 1995 | N/A |
| Metric | RGEN | VNO |
|---|---|---|
| Price | $123.31 | $32.04 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 10 |
| Target Price | ★ $167.67 | $33.00 |
| AVG Volume (30 Days) | 999.5K | ★ 1.6M |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 2.52% |
| EPS Growth | ★ 286.96 | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $141,236,000.00 | N/A |
| Revenue This Year | $14.30 | N/A |
| Revenue Next Year | $14.52 | $5.42 |
| P/E Ratio | $840.47 | ★ $7.08 |
| Revenue Growth | ★ 35.10 | N/A |
| 52 Week Low | $109.50 | $24.57 |
| 52 Week High | $175.77 | $43.37 |
| Indicator | RGEN | VNO |
|---|---|---|
| Relative Strength Index (RSI) | 51.76 | 70.46 |
| Support Level | $121.25 | $25.19 |
| Resistance Level | $130.12 | $32.81 |
| Average True Range (ATR) | 6.50 | 0.86 |
| MACD | 0.60 | 0.24 |
| Stochastic Oscillator | 43.50 | 86.78 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
Vornado Realty Trust is a fully integrated real estate investment trust with a portfolio of New York City office, retail, and multifamily assets, and the developer of the new Penn District. While concentrated in New York, the trust also owns assets in both Chicago and San Francisco. It generates revenue in the form of property rentals, fees charged for trade shows, parking revenues, management and leasing fees, etc. Vornado operates in the following reportable segments: New York (its key revenue-generating market) and Other.